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1054-134 Oral Rapamycin Attenuates Progresslon of 
Atherosclerotic Plaque in ApoE Knockout Mice 
Raibabu Pakala, Mary Susan Burnett, Cindy P. Gulick, Jana Fournadjiev, Laurent 
Leborgne, Edward F. Cheneau, David Hellinga, Stephen E. Epstein, Ron Waksman, 
Washington Hospital Center, Washington, DC 
Background: Rapamycin, a macrorlide antibiotic has been shown to inhibit in stent rest- 
enosis when delivered locally by drug eluting stents. In order to determine the effective- 
ness of oral rapamycin on proliferative vascular diseases, we tested the effect of oral 
rapamycin on atherosclerotic plaque progression. 
Methods: Eight week old ApoE knock-out (ApoE) mice were either fed with normal 
mouse diet contalnlng 0.25% cholesterol (Co&l) or with ConD containing 100 wgkg 
rapamycin (RapaD). Eight weeks after starting on the diet anmals were weighed, blood 
samples were drawn, euthenized and the hearts were dissected out, fixed in neutral-buff- 
ered formalin, embedded I” croyomatrix, sectioned and stained with Oil-Red-O and 
counterstained with Harris modified hematoxylin. Rapamycin levels in the blood were 
determined and lesion area of 5 sections from each mouse was measured. 
Results: Mice fed with RapaD weighed less then the ones fed with ConD (18.5 * 1.59 
vs. 20.6 * 0.9g, p = 0.01). 117 f 7 pglml of rapamycin was detected in the blood of mice 
fed with RapaD whereas, none could be detected in the blood of mice fed with ConD. 
Plaque area of the mice fed with RapaD is 47% less then the plaque area of the mice fed 
with Con0 (0.185 r 0.07 mm vs. 0.35 f- 0.076 mm, p = 0.001). 
Conclusion: Oral administration of rapamycin is effective in attenuating the progression 
of atherosclerosis plaque in the mice, and may have a role when given sytemically in 
halting the progression of atherosclerosis I” addition to its effect of restenosis prevention. 
1054-135 Does Helicobacter pylorilnfection Relate to the 
Prevalence of Coronary Artery Disease? 
Conafeng Xu, Yukun Luo, Yuhong Niu, Shuangjie LI, Ymg Zhen Yang, Hao Zhu Chen. 
Sidong Xiong, Junbo Ge, Shanghai Institute of Cardiovascular Disease, Zhongshan 
Hospltal, Shanghai, People’s Republic of Chma, Fudan University, School of Medicine, 
Shanghai, People’s Republic of China 
HelicobacferpylonfH~ IS one of the most widespread infectious agents which can cause 
serious diseases. Some epidemiological studies showed that Helicobacterpylorimight 
be involved III the pathogenesis of atherosclerosis and there are also negative findings. 
The present research was to elucidate the possible relationship between Helicobacter 
pylon’ infection and coronary artery dwase (CAD) in a large cohort obtained bothin vim 
and in wtro bases. Blood samples from 672 patients underwent coronary angiography 
were tested for serum C-reactive protein (CRP) and specific IgG and IgM antibodies 
against Helicobacterpylon by ELISA. Among which, 488 cases were diagnosed as coro- 
nary artery disease (CAD) and the other 184 cases were grouped as non-CAD controls. 
Df the 488 CAD patients, 317(64.9%) had HP-specific IgG antibodies; while in the control 
group, 100 (54.5%) had HP-specific IgG anbbodies. HP-specific IgM were not found at all 
?.erum samples examined. CAD prevalence was 76.02% in HP-specific IgG-seropositive 
and 67.06% in HP-specific IgG-seronegative patients. The data showed no significant 
relationshIp between Helicobacter pylori and CAD after adjustment for traditional athero- 
sclerosis risk factors. PCR aimed lo detect Helicobacterpylor~specific gene showed that 
there was no Helicobacterpylonpresent in the atherosclerotic lesions of coronary artery 
samples obtained from CABG operations. CRP level, an inflammatory marker, was sig- 
nificantly higher ln atherosclerosis patients than that of non-atherosclerosis 
(59.122&37.945 vs 28.708+17.612, P=O.OOOl), but Hekobecterpylori seropositiwty is 
not a predictor of risk for elevated CRP levels. In addition, Helicobacter pyiori could not 
change expression of MCP-1 and RANTES of human umbilical vein endothelial cell 
(HUVEC) ECV-304. Though inflammation was associated with atherosclerosis, but thts 
study revealed no relationship between Helicobacter pyloriend CAD. 
1054-l 36 C-Reactive Protein, Clinical Presentation, and lschemic 
Activity in Patients With Chest Pain and Normal 
Coronary Angiograms 
Piui Carmine, Cosin-Sales Juan, Brown Sue, Kaski Juan Carlos, St. George’s Hospital 
Medical School, London, United Kingdom 
Background. High sensitive C-reactive protein (hs-CRP), a marker of inflammation, has 
been related to atherogenesis, endothelial dysfunction and coronary events. Endothelial 
activation and microvascular dysfunction leading to myocardial ischemia has been 
shown lo occur in patients with typical chest pain and normal coronary arteriograms 
(CPNCA). However, the relationship between hs-CRP and clinical features of CPNCA 
patients has not been previously investigated. We sought to investigate the relationship 
among hs-CRP. clinical characteristics, exercise stress test responses and daily life ST 
segment changes in patients with CPNCA. Methods. We studied 137 consecutive 
CPNCA patients (mean age 57+9. 33 men). All patients completed standard&d angina 
questionnaires, underwent exercise stress testing (EET) and 24.hour ambulatory ECG 
monitoring as well hs-CRP measurements, which were carried out at study entry. 
Results.Eighly-six patients had chest pain and z. 1 mm ST segment depression during 
stress testing and 61 had ischemic ST segment shift during ambulatory ECG monitoring. 
hs-CRP levels were significantly higher in patients with frequent ( Z 5 episodes/week) 
and prolonged chest pain episodes, in patients with a positive ETT (2.6: 2.8 mg/L vs 1 .l 
-+ 1 .I mg/L) and in those with at least one episode of ST segment depression during 
Halter monitoring (3.42 3.1 vs 0.9 + 0.7 mg/L) compared to those with negative tests and 
occasional chest pain during daily life. Moreover, we found a direct correlarion between 
hs-CRP concentration and number of ischemic episodes during the ambulatory monitor- 
ing (r = 0.65, pcO.OOl), as well as with the magnitude of ST segment depression on exer- 
cise testing (w-0.43. pcO.001). Multivariate logistic regression analysis showed that hs- 
CRP concentration was the only independent vanable capable to predict positive findings 
on Halter (OR:3.35, Cl:2 16-5.19) and exercise test results (OR:l.83. Cl:l.31-2.56). 
Conclusion. hs-CRP correlates with symptoms and markers of ischemic activity in 
CPNCA patlents.Whether hs-CRP is related to the physiopathology of chest pain in 
CPNCA patients desires futher investigation. 
1054-l 37 Mechanical Disruption of Atherosclerotic Plaques 
During Percutaneous Coronary Intervention Results in 
Acute Plasma Increases in Oxidized Low-Density 
Lipoprotein and Lp(a): Implications for Understanding 
Vulnerable Plaques 
Sotirlos Tsimikas Herbert K. Lau. Kyoo-Rok Han, Elizabeth R. Miller, Joseph Juliano, 
Joseph L. W&turn, Bradley H. Strauss. University of California San Diego, La Jolla, CA, 
University of Toronto, Toronto, Canada 
Background: The role of oxidized LDL (OxLDL) in plaque rupture is not established. This 
study was performed to establish whether OxLDL is released from atherosclerotic 
plaques during mechanical plaque disruption. Methods: 143 patients with stable angina 
undergoing successful balloon angioplasty or stenting (PCI) had 9 serial blood samples 
drawn over 6 months. Plasma measurements were made of OxLDL. using antibody E06, 
which detects minimally oxidized phospholipids (OxLDL-EOG). We also measured IgG 
and IgM autoantibodies (ABs) to malondialdehyde(MDA)-LDL, a model oxidation-specific 
epitope. Results: OxLDL-EO6 and Lp(a) increased 35*45% and .30*117% (PcO.001 for 
both, Figure) immediately post procedure, then returned to baseline by 24 hours. A 
strong correlation was noted between OxLDL-EO6 and Lp(a) (rc0.87, p~O.0001). Both 
IgG (-8.2+25.5%, PcO.001) and IgM (-6.6*15.9%, P<O.OOl) ABs actually decreased 
post-procedure, suggesting acute consumption (removal as immune complexes) of pre- 
existing circulating OxLDL ABs due to acute release of OxLDL antigens. Conclusion: 
Mechanical dIsruption of atherosclerotic plaques in stable patients results in acute 
increases of OxLDL-EO6 and Lp(a), suggesting acute release from disrupted plaques or 
acute generation and/or synthesis of these atherogenic lipoproteins This observation 
has important implications in understanding spontaneous plaque disruption and suggests 
novel diagnostic and therapeutic modalities targeting OxLDL in the vessel wall. 
* Paoul 
